BD announced the appointment of Gary Sorsher as chief quality officer, effective immediately. The move underscores the medical technology company’s focus on enhancing operational quality amid heightened regulatory oversight in healthcare supply chains.
Sorsher, who previously served as vice president of quality at BD’s diabetes care business, will report directly to BD President and CEO Tom Polen. The appointment reflects the company’s commitment to strengthening quality systems and compliance frameworks across its global operations.
BD, a leading provider of medical supplies and technologies, has faced increased scrutiny from regulators in recent years regarding product quality and manufacturing standards. The company has implemented multiple initiatives to address these concerns, including expanded quality audits and process improvements.
The appointment comes as BD continues to navigate a complex regulatory environment, particularly in the U.S. and Europe, where healthcare supply chains remain under close examination. Sorsher’s role will involve overseeing quality strategy, risk management, and cross-functional collaboration to ensure adherence to stringent regulatory requirements.
A BD spokesperson confirmed the appointment but declined to provide additional details on Sorsher’s background or specific responsibilities. The company has not disclosed a transition timeline for his predecessor.
